| Answers |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Investing > Investing for the Long Term Pays Off |
|
Answers - Investing for the Long Term Pays Off
The investor that keeps a steady pace for the long term is more likely to achieve his or her goals than the investor that follows the quick profits. It is true, time According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product can be your best friend. Time gives compounding time to work. The interest on your money turns is added to your principal and earns you even more interest. But if yo ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in u wait too long, time can't help you as much. For example, Let's look at three investors, aged 25, 35 and 45. All are saving for retirement. Each invests $2,000 each lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. year and earns 8% annually. At age 65, the investor who started at age 25 will have over $585,000. The investor who started at age 35 will have just over $250,000. T here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe he investor who waited until 45 to start investing will have $98,900. Waiting 20 years to begin investing cost the investor $486,100. In fact, only $40,000 of that wo d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ld have come directly out of the investor's pocket -- $446,100 of that is lost interest. Wow. Starting 10 years earlier can even make a significant difference. The i ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc nvestor who starts at the age of 45 will earn three times as much as the investor who starts at the age of 55. Let's look at this a different way. How much would an easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi nvestor need to invest to accumulate $750,000 by the age of 65. They earn 8% annually and there are no taxes or inflation in our examples. The investor who starts at nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically 25 will need to invest $215 per month. The investor who starts at age 35 will need to invest $500 per month. The investor who waits until 45 will have to invest $1,6 and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ 0. And the investor who waits until 55 will have to invest $4,072 every month! You can see why starting early actually saves you money out of your monthly budget. If ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi you think that you will have a hard time affording it now, imagine trying to afford that much more in decade. The earlier you start, the less you will have to inves ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a t out of your pocket in order to reach your goal. These examples are to prove a point. The true reality is that you probably won't earn a flat 8% annually. Some year dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod will be better than others. Sometimes you will lose and sometimes you will win. If you invest for the long term, you have the time to correct your mistakes. You don cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin 't have to hit a true win every time in order to hit your goal. You have room to maneuver. Short-term investors who make the wrong move can be financially hurt in a b tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen g way. Long-term investors can absorb some loss. This is especially true if you have a diversified portfolio that takes into account your investment goals and your r t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel isk tolerance. If the market goes down -- which is likely over thirty years -- you will probably still be able to reach your goals. But if you are an investor with o ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ly 10 years until retirement, a market downturn can be a disaster. There is no longer any room for error. Time isn't smoothing things out for you any more. The market y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products will go up and it will go down. If you start early, you will have a better chance of coming out on top. I know that the time may have passed for you. There is nothi . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de g you can do about the time that you have lost. The key is to not lose any more time. The longer you wait, the more risky your investments become, the more you have t elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip o contribute and the more stress you have in your life. Start right now investing in your future. Every year that goes by costs you thousands of dollars in the future tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Tired of Google.com? - Try Ask.com
|